MiMedx Group
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
17.1010.5910.757.88
Price/Sales ratio
1.961.661.631.43
Earnings per Share (EPS)
$0.41$0.67$0.66$0.9

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
196.1033.7078.3821.28-6.30-31.69-19.94-64.80-10.3915.14-12.42-12.42
Price/Sales ratio
10.315.293.834.280.522.703.952.571.173.171.400.52
Price/Book Value ratio
13.659.197.0518.663.8023.56-6.55K8.12K-17.447.15-20.8523.56
Price/Cash Flow ratio
72.5952.7736.3321.885.28-20.56-32.48-336.29-17.5438.15-20.96-20.56
Price/Free Cash Flow ratio
89.3681.8350.1423.937.33-19.47-28.23-122.25-15.2541.21-18.23-18.23
Price/Earnings Growth ratio
-0.810.09-0.790.000.042.21-0.210.81-0.05-0.050.080.04
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
89.28%89.21%86.77%89.03%89.86%85.60%84.15%83.26%81.96%83.00%81.96%85.60%
Operating Profit Margin
6.00%13.00%7.52%14.39%-1.09%-6.92%-17.87%-1.93%-9.32%11.54%-9.32%-6.92%
Pretax Profit Margin
5.96%12.96%7.39%14.04%-0.94%-8.54%-24.79%-3.88%-11.19%9.52%-11.19%-8.54%
Net Profit Margin
5.26%15.72%4.88%20.15%-8.34%-8.54%-19.85%-3.97%-11.27%20.97%-11.27%-8.54%
Effective Tax Rate
11.79%-21.28%33.87%-43.55%-782.51%0.01%19.91%-2.46%-0.68%-120.15%-0.68%-782.51%
Return on Assets
5.69%21.66%6.19%53.38%-24.40%-15.30%-24.39%-5.47%-17.61%28.21%-17.61%-24.40%
Return On Equity
6.96%27.26%9.00%87.70%-60.37%-74.36%32856%-12542.68%167.87%47.25%-55.17%-60.37%
Return on Capital Employed
7.81%22.32%12.94%61.26%-7.64%-20.74%-31.05%-3.43%-19.52%19.22%-19.52%-20.74%
Liquidity Ratios
Current Ratio
4.653.592.491.061.031.832.71N/AN/AN/A3.081.03
Quick Ratio
4.373.312.140.850.811.692.533.232.773.112.510.81
Cash ratio
2.531.060.670.590.631.021.612.051.511.781.510.63
Days of Sales Outstanding
82.34104.75100.030.740.4639.4566.8558.0058.7161.1659.670.46
Days of Inventory outstanding
147.93134.78200.6398.11160.3677.1396.1596.0499.59140.4399.5999.59
Operating Cycle
230.27239.54300.6798.85160.82116.58163.01154.04158.30201.60114.30116.58
Days of Payables Outstanding
105.50119.84128.8087.61149.1073.7981.3462.2763.8660.4466.8373.79
Cash Conversion Cycle
124.76119.69171.8711.2411.7142.7881.6691.7694.43141.1517.3911.71
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/A0.390.230.250.280.201.101.10
Debt Equity Ratio
N/AN/AN/AN/AN/A1.90-317.98586.91-2.700.33-10.531.90
Long-term Debt to Capitalization
N/AN/AN/AN/AN/A0.641.000.991.580.251.581.58
Total Debt to Capitalization
N/AN/AN/AN/AN/A0.651.000.991.580.25N/A0.65
Interest Coverage Ratio
147.91283.30N/AN/AN/AN/A-5.58N/AN/AN/A-5.09N/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/A-0.60-0.63-0.04-0.360.55N/AN/A
Company Equity Multiplier
1.221.251.451.642.474.85-1.34K2.29K-9.531.67-9.534.85
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.140.100.100.190.09-0.13-0.12-0.00-0.060.08-0.06-0.13
Free Cash Flow / Operating Cash Flow Ratio
0.810.640.720.910.711.051.152.751.150.921.150.71
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/A-0.60-0.63-0.04-0.360.55N/AN/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/A-10.50N/AN/AN/AN/AN/A-10.50
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A